Pulmonary Fibrosis

Lung Disease

PulmonaryFibrosis

What is Pulmonary Fibrosis?

Pulmonary fibrosis is a disease that scars the lungs, causing intricate pulmonary passageways to thicken and harden and obstructing the free passage of oxygen through the walls of the lungs’ tiny air sacs (alveoli) into the bloodstream. The resulting lack of oxygen in the bloodstream leaves pulmonary fibrosis sufferers short of breath even after periods of prolonged rest. Idiopathic pulmonary fibrosis is a form of pulmonary fibrosis with no known cause. Pulmonary fibrosis is a progressive disease that varies in the rate of degeneration from person to person.

Pulmonary fibrosis is a subset of a group of conditions referred to as interstitial lung disease.

The term interstitial lung disease refers to conditions that lead to inflammation or scarring of the lung’s delicate tissues. Some autoimmune disorders, specifically connective tissue disorders like rheumatoid arthritis can cause interstitial lung disease. Scarring of the lungs is irreversible. However, treatment options are available.

Whos Affected?

Typically, sufferers of pulmonary fibrosis do not live more than 5 years after a diagnosis.

Idiopathic pulmonary fibrosis has no specific demographic. However it does affect men more than women. It typically occurs in individuals between the age of 50 and 70, and has an increased risk for individuals who smoke cigarettes.

The symptoms of pulmonary fibrosis differ by individual.

If you would like to find out more about our available treatment options, please contact one of our patient care coordinators today at (800) 729-3065 to schedule a free consultation.

Related Posts

  • Lung GraphicPulmonary fibrosis is a condition characterized by the development of scarring (fibrosis) in and around the air sacs (alveoli) of the lungs. The resulting thickening and stiffening of lung tissue ... Read more
  • Coping with Pulmonary Fibrosis: 4 Tips for Breathing BetterWhen faced with the prospect of coping with pulmonary fibrosis, sometimes the traditional medications aren’t always enough. In dealing with the day-to-day symptoms sometimes it takes significant change to one’s ... Read more

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.